Marker Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Marker Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Marker Therapeutics Inc
Rating: 2.06683325
Author: Trendlyne DVM scores

about

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...

1.81 0.05 (2.84%)

55.53% Fall from 52W High

234.1K

XNAS Volume

XNAS 16 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

22.3 / 100

Technically Moderately Bullish

60.3 / 100

1Yr Price target upside is 335%

3 analysts

Marker Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Marker Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...

55.53% Fall from 52W High

SWOT Analysis

Marker Therapeutics Inc Live Price Chart